Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cardiovascular diseases 13

Cardiovascular Diseases

MedTech News for QuantuMDx, Medtronic, Exactech, and ProciseDx

Notizia - Recent Pharma, Healthcare and Biotech Happenings

QuantuMDx & Menarini’s Agreement; TruClear System Launched by Medtronic in India; FDA 510(k) Clearance for TriVerse Primary Knee Replacement System; FDA Clearance to ProciseDx’s Reactive Protein (CRP) Assay and ProciseDx Instrument; Evolution Optiks’s Enrollment of LFR-260 Phoropter in US; Kardium First-in-Human Clinical Study of the New Globe Pulsed Field System

QuantuMDx and Menarini Announced an Agreement for the Distribution of the Q-POCTM Platform On November 2, 2022, QuantuMDx Group Limited, a UK-based developer of transformational Point-of-Need molecular diagnostics, and A.Menarini Diagnostics S.r.I. (Menarini), announced an exclusive distribution agreement for QuantuMDx’s Q-POC™ platform in UK and France. As per the terms of the contract, QuantuMDx's SARS-CoV-2 assay, Q-POCTM, and its new SARS-CoV-2, Flu A/B, and RSV Respiratory Panel test, which the Company launched earlier this year, will all be marketed, sold, and serviced by Menarini. Initial distribution to the UK and France will be covered by the fiv...

Explore More...

key-trends-in-the-healthcare-industry-in-2021

Healthcare in 2021: Top Disruptions Bound To Impact The Way Healthcare Is Delivered

Smoking Cessation Market | Quitting Tobacco | Nicotine-addiction |

The Mesh of the Generics and the Potential of Emerging Therapies in the Smoking Cessation Market

recent-pharma-biotech-news-updates-gilead-vir-teladoc-tessera-dexcom-verve

Gilead and Vir collaborate; Tessera scores $230M; Teladoc & Dexcom bring CGM Tech; Verve unveils lead candidate

medical-tourism-types-challenges-risks-drivers-and-top-countries

Medical Tourism: Road to Affordable and Quality Medical Care

Pfizer’s Somatrogon; SCONE device; ATG-010; SanBio in Neurology

Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results

Amyotrophic Lateral Sclerosis Pipeline

Top 10 Most Promising Drugs In The Amyotrophic Lateral Sclerosis Treatment Landscape

Digital Therapeutics

Treating Patients with Software: Digital Therapeutics

wearable-technology-devices-in-the-healthcare-wellness-and-fitness-industry

Will Wearable Devices be Streamlined in Healthcare?

Creating Future of MedTech Industry with Artificial Intelligence

Creating Future of MedTech Industry with Artificial Intelligence

Different-Types-of-Alternative-Medicine

The State of Alternative Medicine In The Healthcare

Healthcare-Delivery-System

Healthcare Delivery System: What lies in the future?

Default Blog Image

Boehringer Ingelheim; Roche demonstrated new analyses of their drugs in patients with ILDs during the American Thoracic Society (ATS) Virtual conference

Familial Chylomicronemia Syndrome Market

Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

recent-pharma-news-and-update

Olema raises $54M; T3 Pharma bags $27M to advance bacterial cancer therapy program; Biofourmis and Chugai’s Collaboration; A new study on averting heart attack

Leading-Causes-of-Death-Worldwide

What are the Top Five Leading Causes of Deaths in the World?

Dilated Cardiomyopathy Market

With the Advances in Regenerative Therapy to Offer Curated Treatment Options, Off-label Therapy Market is Set to Decline for Dilated Cardiomyopathy

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly